CCL2 and neoplasm: Our working hypothesis is that the presence of tumor-infiltrating immune cells, here represented as macrophages characterized by the markers CD68, CD163, and CCL2, could be associated with a better prognosis, but that chemotherapy may not add an advantage for prognosis.